EMAIL US: customerservice@franklinyoung.com
CALL US: (618) 724-2780 / (909) 931-5012
CALL US: (618) 724-2780 / (909) 931-5012
Back to Previous Page
ITEM#: 3042-SML166825MG
MFR#: SML1668-25MG
Pre-clinical studies show that tipifarnib has antiproliferative effects on pancreatic cancer cell lines at clinically relevant concentrations (concentration that inhibits 50% growth [IC50] from 9.5 to 500 nmol/L). It also exhibits marked growth retar
| Product Name | Description | Item# | QTY | |
|---|---|---|---|---|
Tipifarnib >=98% (HPLC)
|
Pre-clinical studies show that tipifarnib has antiproliferative effects on pancreatic cancer cell lines at clinically relevant concentrations (concentration that inhibits 50% growth [IC50] from 9.5 to 500 nmol/L). It also exhibits marked growth retar | 3042-SML16685MG | EA | |
Berteroin, 25mg
|
Berteroin, 25mg | 2706-B166825MG | EA | |
HMG-CoA reductase inhibitor used to lowe
|
HMG-CoA reductase inhibitor used to lower cholesterol and li | 2706-C166825MG | EA | |
|
Anti-CHMP3 serum, from rabbit
|
Charged multivesicular body protein 3 (UniProt: Q9Y3E7; also known as Chromatin-modifying protein 3, CHMP3, Neuroendocrine differentiation factor, Vacuolar protein sorting-associated protein 24, hVps24) is encoded by the CHMP3 (also known as CGI149, | 3042-ABS166825UL | EA | |
Darifenacin hydrobromide >=98% (HPLC)
|
Darifenacin hydrobromide >=98% (HPLC) | 3042-SML110210MG | EA |